Lipoic acid as adjunctive therapy for sepsis-related moderate-to-severe ARDS: a single-center, randomized, double-blind, placebo-controlled phase II trial

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2025
This article has no abstract
Epistemonikos ID: ba030c0dfc862133b5b4dc1549c6e08d129a401f
First added on: Jan 17, 2026